Vestal Point Capital »

Agios Pharmaceuticals shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $34M 760k 44.43

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Agios Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Bellevue Group
T. Rowe Price Associates
Armistice Capital
State Street Corporation
Erste Asset Management GmbH
Macquarie Group
Leucadia National Corporation
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
BVF
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals